ECM
DVAX

Endurant Capital Management’s Dynavax Technologies DVAX Stock Holding History

Endurant Capital Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-41,288
Closed -$302K – 59
2019
Q1 		$302K Buy
+41,288
New +$404K 0.12% 66
2017
Q4 		– Sell
-50,500
Closed -$1.09M – 78
2017
Q3 		$1.09M Sell
50,500
-9,358
-16% -$148K 0.33% 66
2017
Q2 		$578K Sell
59,858
-113,600
-65% -$738K 0.16% 82
2017
Q1 		$1.03M Buy
173,458
+116,658
+205% +$561K 0.33% 66
2016
Q4 		$224K Buy
+56,800
New +$416K 0.09% 70

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Endurant Capital Management's DVAX Position: Q2 2019 in Review

Endurant Capital Management sold out of Dynavax Technologies (DVAX) in Q2 2019, closing a stake of 41,288 shares — an estimated $302K sold.

Endurant Capital Management first reported a position in DVAX in Q4 2016 and held it in 5 quarters. The position peaked at $1.09M in Q3 2017. 127 funds tracked by Wall St. Rank hold DVAX as of Q2 2019.

  • Endurant Capital Management reported no remaining Dynavax Technologies position as of Q2 2019 after selling out during the quarter.
  • Endurant Capital Management sold 41,288 Dynavax Technologies shares in Q2 2019, an estimated $302K.
  • Endurant Capital Management first reported a position in Dynavax Technologies in Q4 2016 and held it in 5 quarters.
  • Endurant Capital Management's Dynavax Technologies position peaked at $1.09M in Q3 2017.
  • 127 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2019.

Based on Endurant Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.